Johnson & Johnson (JNJ) Dividend Yield & History

JNJ$280.41-0.37 -0.13%
Drug Manufacturers - GeneralMega CapHigh Quality
Compare
Market cap$675.03BEnterprise value$692.93BRevenue (TTM)$99.33BMarket positionTop 5%

Score

38
Bearish
Value
18
Quality
69
Growth
26
$280.41Price
$675.03BMarket cap
41.92P/E
24.93Forward P/E
1.88%Dividend yield

Yield is based on dividends paid in the past 12 months. 2026 isn't counted in streaks until the year ends.

1.88% is the yield on Johnson & Johnson at $280.41, from $5.28 a share over the past year.

Johnson & Johnson raised the yearly dividend in every year from 1970 through 2025.

From $1.30 to $1.34 on 26 May 2026: the Johnson & Johnson quarterly dividend, up 3.1%.

79% of Johnson & Johnson earnings went out as dividends over the past year.

A Johnson & Johnson dividend is paid quarterly.

Johnson & Johnson trades without the dividend from 24 November 2026, with payment on 8 December 2026.

Johnson & Johnson grew its dividend 5.2% a year across five years.

Our records cover 228 payments from 1970 to 2026.

At today's yield, $10,000 invested would receive about $188 a year in dividends before tax, if payments stay the same. Dividends can be cut.

Learn: How to read a dividend

Full JNJ quote · Forecast · Academy

Questions

When did JNJ last raise the dividend?

26 May 2026: $1.30 then $1.34.

How often does JNJ pay a dividend?

JNJ paid a dividend 4 times in the past year.

How many years has JNJ raised the dividend?

Higher every year, 1970 through 2025 ($5.14 in 2025).

What is the JNJ dividend yield?

Yield on Johnson & Johnson: 1.88%.

How long after the JNJ ex-dividend date is the cash paid?

14 days.

Johnson & Johnson (JNJ) Dividend Yield & History

JNJ price $280.41 -0.37 -0.13%

Ticker
JNJ
Price
$280.41
Change
-0.37 -0.13%
Market cap
$675.03B
P/E
41.92
Forward P/E
24.93
Dividend yield
1.91%
Beta
0.23
Sector
Healthcare
Industry
Drug Manufacturers - General
Stocklytics score
38
Value
18
Quality
69
Growth
26

Stocklytics score rationale: value 18, quality 69, growth 26.

AI Score 58. The score reflects positive profitability, with a net margin of 0.162, and shareholder income through a dividend yield of 0.0193. It is moderated by a P/E ratio of 41.4203, a price-to-book ratio of 8.2016, and the absence of provided growth, estimates, and price-trend data

Summary

Johnson & Johnson operates in Healthcare within the Drug Manufacturers - General industry. The company reports a net margin of 16.2% and a dividend yield of 1.9%.

Valuation

The shares trade at a P/E ratio of 41.4 and a price-to-book ratio of 8.2. These multiples indicate a valuation that should be weighed against the company’s profitability and available growth information.

Quality

A net margin of 16.2% indicates that Johnson & Johnson retains a meaningful portion of revenue as profit. The provided facts do not include balance-sheet, cash-flow, or return-on-capital measures.

Growth

No revenue, earnings-growth, estimate-revision, or operating-growth figures are provided. Growth assessment is therefore limited by the available information.

Risks

The P/E ratio of 41.4 and price-to-book ratio of 8.2 create valuation risk if future business performance does not support those multiples. The supplied facts do not provide price-trend, estimate, or company-specific risk data.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener